A University of the Pacific team has developed a single-dose injection to counter the effects of fentanyl and other opioid ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...